Mark J. Gergen
2014 - Mirati Therapeutics
In 2014, Mark J. Gergen earned a total compensation of $1.3M as Executive Vice President and Chief Operations Officer at Mirati Therapeutics, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $92,360 |
|---|---|
| Option Awards | $762,828 |
| Salary | $399,180 |
| Other | $2,975 |
| Total | $1,257,343 |
Gergen received $762.8K in option awards, accounting for 61% of the total pay in 2014.
Gergen also received $92.4K in non-equity incentive plan, $399.2K in salary and $3K in other compensation.
Rankings
In 2014, Mark J. Gergen's compensation ranked 6,551st out of 13,032 executives tracked by ExecPay. In other words, Gergen earned more than 49.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,551 out of 13,032 | 50th |
Division Manufacturing | 2,389 out of 4,965 | 52nd |
Major group Chemicals And Allied Products | 804 out of 1,690 | 52nd |
Industry group Drugs | 628 out of 1,369 | 54th |
Industry Pharmaceutical Preparations | 479 out of 1,042 | 54th |
Source: SEC filing on April 19, 2016.
Gergen's colleagues
We found two more compensation records of executives who worked with Mark J. Gergen at Mirati Therapeutics in 2014.